MedTrace Logo

PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients

NCT03039088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 527

Last updated 2018-09-19

Study results available
· View outcomes & findings →

Summary

This is a prospective observational national (France) study with 2 visits 3 months apart (baseline and 12 weeks after TNF alpha blockers initiation). The objective of recruitment is 500 SpA patients (diagnosis according to their treating rheumatologist) initiating a TNF alpha blocker.

The main objective of the study is to evaluate the impact of a concomitant fibromyalgia on the anti-TNF treatment effect in axial Spondyloarthritis in both anti-TNF naïve and pre-exposed patients.

Conditions

  • Axial Spondyloarthritis
  • Fibromyalgia

Interventions

OTHER

Follow-up after 12 weeks after TNF alpha blockers initiation

Sponsors & Collaborators

  • RCTs

    collaborator INDUSTRY

  • Association de Recherche Clinique en Rhumatologie

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-02
Primary Completion
2016-10-04
Completion
2016-10-04

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03039088 on ClinicalTrials.gov